Search results
Michael Tadross. Assistant Professor of Biomedical Engineering at Duke University. I received a B.S. in Electrical & Computer Engineering with a minor in Chemistry at Rutgers; an M.D.-Ph.D. in Biomedical Engineering at Johns Hopkins; and postdoctoral training in Cellular Neuroscience at Stanford.
Michael Tadross is an American film producer and former executive at Paramount Pictures. Films that he either produced or was executive producer include Indecent Proposal, Die Hard with a Vengeance, which became the highest-grossing film of 1995, Eraser, The Devil's Advocate, The Thomas Crown Affair, I Am Legend, Sherlock Holmes and Gangster Squad.
- Appointments and Affiliations
- Contact Information
- Education
- Courses Taught
- In The News
Assistant Professor of Biomedical EngineeringAssistant Professor in NeurobiologyEmail Address:michael.tadross@duke.eduWebsites:M.D. Johns Hopkins University, 2009Ph.D. Johns Hopkins University, 2009BME 590: Special Topics in Biomedical EngineeringBME 493: Projects in Biomedical Engineering (GE)BME 244L: Quantitative Physiology with Biostatistical ApplicationsBME 244L9: Quantitative Physiology with Biostatistical ApplicationsAssistant Professor of Biomedical Engineering. Dr. Tadross' lab develops technologies to rapidly deliver drugs to genetically defined subsets of cells in the brain.
Oct 27, 2019 · Michael Tadross, MD, is an assistant professor in Duke BME, where his lab uses a novel technology dubbed DART, or Drugs Acutely Restricted by Tethering, to deliver pharmaceuticals to specific cells within the brain.
Biomedical Engineering. Assistant Professor of Biomedical Engineering. Michael Raphael Tadross Profile Photo. michael.tadross@duke.edu. Tadross Lab. Research Interests. Our goal is to bridge the gap between the study of brain as a computational device and the search for novel neuropathological treatments.
For Michael Tadross, assistant professor of biomedical engineering at Duke, genetically targeting individual cell types in the brain has long been a hallmark of his research enterprise. His novel technology, dubbed DART (Drugs Acutely Restricted by Tethering) , allows researchers to deliver pharmaceuticals to specific cell types.
